BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8520850)

  • 1. Apolipoprotein A-I-containing lipoproteins and atherosclerosis.
    Leroy A; Dallongeville J; Fruchart JC
    Curr Opin Lipidol; 1995 Oct; 6(5):281-5. PubMed ID: 8520850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice.
    Alam K; Meidell RS; Spady DK
    J Biol Chem; 2001 May; 276(19):15641-9. PubMed ID: 11278646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse cholesterol transport: high-density lipoprotein's magnificent mile.
    Toth PP
    Curr Atheroscler Rep; 2003 Sep; 5(5):386-93. PubMed ID: 12911849
    [No Abstract]   [Full Text] [Related]  

  • 4. Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?
    Quintão EC
    Atherosclerosis; 1995 Jul; 116(1):1-14. PubMed ID: 7488324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
    Atger V; de la Llera Moya M; Bamberger M; Francone O; Cosgrove P; Tall A; Walsh A; Moatti N; Rothblat G
    J Clin Invest; 1995 Dec; 96(6):2613-22. PubMed ID: 8675626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse cholesterol transport and future pharmacological approaches to the treatment of atherosclerosis.
    Krause BR; Auerbach BJ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):375-81. PubMed ID: 11575708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis.
    Forte TM; McCall MR
    Curr Opin Lipidol; 1994 Oct; 5(5):354-64. PubMed ID: 7858910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and genetic control of HDL cholesterol levels.
    Tall AR
    J Intern Med; 1992 Jun; 231(6):661-8. PubMed ID: 1619389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages.
    Harada LM; Carvalho MD; Passarelli M; Quintão EC
    Atherosclerosis; 1998 Jul; 139(1):65-75. PubMed ID: 9699893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-II, HDL metabolism and atherosclerosis.
    Tailleux A; Duriez P; Fruchart JC; Clavey V
    Atherosclerosis; 2002 Sep; 164(1):1-13. PubMed ID: 12119188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis.
    Bruce C; Tall AR
    Curr Opin Lipidol; 1995 Oct; 6(5):306-11. PubMed ID: 8520853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles.
    Adlouni A; El Messal M; Saïle R; Parra H; Fruchart J; Ghalim N
    Atherosclerosis; 2000 Oct; 152(2):433-40. PubMed ID: 10998472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein.
    Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM
    Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and molecular biology.
    Baralle M; Baralle FE
    Curr Opin Lipidol; 2000 Dec; 11(6):653-6. PubMed ID: 11086339
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent advanced knowledges related with lipoprotein metabolism].
    Shimada K; Mokuno H
    Nihon Rinsho; 1999 Dec; 57(12):2717-22. PubMed ID: 10638202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse cholesterol transport and atherosclerosis regression.
    Spady DK
    Circulation; 1999 Aug; 100(6):576-8. PubMed ID: 10441091
    [No Abstract]   [Full Text] [Related]  

  • 20. HDL: the metabolism, function, and therapeutic importance.
    Wang M; Briggs MR
    Chem Rev; 2004 Jan; 104(1):119-37. PubMed ID: 14719972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.